{"id":"https://openalex.org/W1996607203","doi":"https://doi.org/10.1056/nejmp1203020","title":"Statins: Is It Really Time to Reassess Benefits and Risks?","display_name":"Statins: Is It Really Time to Reassess Benefits and Risks?","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-25","ids":{"openalex":"https://openalex.org/W1996607203","doi":"https://doi.org/10.1056/nejmp1203020","mag":"1996607203","pmid":"https://pubmed.ncbi.nlm.nih.gov/22533536"},"language":"en","primary_location":{"id":"doi:10.1056/nejmp1203020","doi":"https://doi.org/10.1056/nejmp1203020","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmp1203020","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1996607203"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032424150","display_name":"Allison B. Goldfine","orcid":"https://orcid.org/0000-0002-0345-1048","observed_orcids":["https://orcid.org/0000-0002-0345-1048"]},"institutions":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Allison B. Goldfine","raw_affiliation_strings":["From Harvard Medical School and the Section of Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center \u2014 both in Boston","Harvard Medical School and the Section of Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center \u2014 both in Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Harvard Medical School and the Section of Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center \u2014 both in Boston","institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Harvard Medical School and the Section of Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center \u2014 both in Boston","institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032424150"],"corresponding_institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":10.5249,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.98804769,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"366","issue":"19","first_page":"1752","last_page":"1755"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":1.0},{"id":"https://openalex.org/keywords/drug-labeling","display_name":"drug labeling","score":0.6620000004768372},{"id":"https://openalex.org/keywords/diabetes-risk","display_name":"diabetes risk","score":0.7260000109672546},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9729999899864197},{"id":"https://openalex.org/keywords/fasting-serum-glucose","display_name":"fasting serum glucose","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cardiovascular-benefits","display_name":"cardiovascular benefits","score":0.8560000061988831},{"id":"https://openalex.org/keywords/fda-drug-labeling","display_name":"FDA drug labeling","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.928824245929718},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.8059725761413574},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.7810676693916321},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6121436953544617},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5039641261100769},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4442558288574219},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4372597634792328},{"id":"https://openalex.org/C2910980524","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","level":3,"score":0.4306357502937317},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35414552688598633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3341163396835327},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30067598819732666},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.17508220672607422}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmp1203020","doi":"https://doi.org/10.1056/nejmp1203020","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmp1203020","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:22533536","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22533536","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2019618316","https://openalex.org/W2097870088","https://openalex.org/W2103108681","https://openalex.org/W2115169717","https://openalex.org/W2121535401","https://openalex.org/W2137983259","https://openalex.org/W3022401702"],"related_works":["https://openalex.org/W1985252547","https://openalex.org/W2086524674","https://openalex.org/W2324524713","https://openalex.org/W2007994317","https://openalex.org/W7220551742","https://openalex.org/W4313544659","https://openalex.org/W2040588962","https://openalex.org/W2334918336","https://openalex.org/W2133758607"],"abstract_inverted_index":{"The":[0],"Food":[1],"and":[2,22],"Drug":[3],"Administration":[4],"has":[5],"added":[6],"information":[7],"to":[8],"statin":[9],"labels":[10],"regarding":[11],"an":[12],"effect":[13],"on":[14],"diabetes,":[15],"noting":[16],"reported":[17],"increases":[18],"in":[19],"glycated":[20],"hemoglobin":[21],"fasting":[23],"serum":[24],"glucose":[25],"levels":[26],"but":[27],"adding":[28],"that":[29,32],"it":[30],"believes":[31],"the":[33,37],"cardiovascular":[34],"benefits":[35],"outweigh":[36],"risks.":[38]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1996607203","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
